LINDA HARDY: Open Payments
NPI 1902301633 · KINGWOOD, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$725 in 35 payments from 15 companies in 2025. Trend: 2023 $15 · 2024 $442 · 2025 $725
Food & beverage: $725
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 10 | $169 |
| AstraZeneca Pharmaceuticals LP | 4 | $74 |
| PFIZER INC. | 2 | $63 |
| Lilly USA, LLC | 3 | $62 |
| Exact Sciences Corporation | 3 | $61 |
| Madrigal Pharmaceuticals | 1 | $48 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $39 |
| Esperion Therapeutics, Inc. | 2 | $35 |
| GlaxoSmithKline, LLC. | 2 | $35 |
| Inspire Medical Systems, Inc. | 1 | $32 |
Products named: PREVNAR 20, MOUNJARO, Cologuard Collection Kit, REZDIFFRA, FARXIGA, Kerendia, NEXLETOL, SHINGRIX.
Industry payments across TX — which companies pay providers there.
